Education
About Us
Working with TipRanks
Follow Us
Adaptive Biotechnologies (ADPT)
NASDAQ:ADPT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 276.98M | $ 178.96M | $ 170.28M | $ 185.31M | $ 154.34M |
| Gross Profit | $ 205.62M | $ 106.88M | $ 94.72M | $ 127.40M | $ 105.04M |
| Operating Income | $ -57.12M | $ -162.55M | $ -227.03M | $ -200.19M | $ -208.97M |
| EBITDA | $ -29.85M | $ -128.76M | $ -189.27M | $ -175.21M | $ -193.34M |
| Net Income | $ -59.50M | $ -159.49M | $ -225.25M | $ -200.19M | $ -207.28M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 226.98M | $ 222.29M | $ 346.40M | $ 498.20M | $ 353.06M |
| Total Assets | $ 512.74M | $ 539.38M | $ 661.13M | $ 856.62M | $ 923.34M |
| Total Debt | $ 280.58M | $ 89.39M | $ 98.77M | $ 108.00M | $ 111.74M |
| Net Debt | $ 210.09M | $ 41.47M | $ 33.71M | $ 17.97M | $ -27.32M |
| Total Liabilities | $ 287.74M | $ 336.89M | $ 352.86M | $ 392.52M | $ 319.24M |
| Stockholders' Equity | $ 218.79M | $ 202.71M | $ 308.40M | $ 464.17M | $ 603.99M |
| Cash Flow | |||||
| Free Cash Flow | $ -48.95M | $ -98.88M | $ -167.02M | $ -200.29M | $ -254.47M |
| Operating Cash Flow | $ -45.99M | $ -95.21M | $ -156.32M | $ -183.94M | $ -192.73M |
| Investing Cash Flow | $ 37.95M | $ 77.79M | $ 129.65M | $ 2.90M | $ 181.21M |
| Financing Cash Flow | $ 30.40M | $ 241.00K | $ 2.25M | $ 132.26M | $ 27.15M |